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Takayasu’s Arteritis: An Indian PerspectiveIntroduction
Takayasu’s arteritis (TA) is a chronic vasculitis involv-
ing mainly the aorta and its branches, as well as the
pulmonary and coronary arteries. The classical defini-
tion of Takayasu’s Arteritis is that of chronic, progres-
sive, inflammatory, occlusive disease of the aorta and
its branches.
Epidemiology
Although TA has a worldwide distribution, it is
observed frequently in Asia than in North America.
TA is the most common cause of renovascular hyper-
tension in India, China, Korea, Japan and other coun-
tries of South East Asia.1,2
Aetiology
The aetio-pathogenesis of the disease remains enig-
matic. An infectious etiology has been considered
with one series reporting active tuberculosis infection
in 60% of autopsy cases of non-specific aortitis.3 Vari-
ous mechanisms such as post-infective, autoimmune,
ethnic susceptibility and a genetic predisposition have
been postulated. Autoimmunity appears to be the
most plausible mechanism. Both cellular and humoral
factors are probably involved. Defective T lymphocyte
regulation and anti-endothelial antibodies have also
been implicated. A provocative hypothesis put for-
ward by Kothari S.S. explores the possibility of BCG
vaccination as a triggering factor for TA in a suscep-
tible population.4 A 65 M heat shock protein (HSP)
which plays a role in vascular injury has been shown
to be a component of both BCG and Mycobacterium
tuberculosis.4 Kinare SG et al. noted a high incidence
of tuberculin positive skin hypersensitivity in patients
of Takayasu arteritis.5
Several studies have proposed various human
leukocytes antigen (HLA) associations, suggesting
a genetic pre-disposition for the disease. The geo-
graphical incidence and the occasional familial
occurrence also suggest the role of genetic factors.4/000578 + 05 $32.00/0  2007 Published by Elsevier Ltd.Takeuchi Y et al. demonstrated an association between
Takayasu’s arteritis and HLA-D gene at the genomic
level.6 Khraishi MM et al. in 1992, reported a negative
association between this disease and HLA-DR 1,
implying a protective association with Takayasu’s ar-
teritis.7 The tendency for the disease to affect women
of reproductive age has suggested a potential role for
hormonal influences in the pathogenesis of Takayasu’s
arteritis. An association between the disease and spe-
cific HLA types A9, A10, B5, BW52, DHO, and DW12
in Japanese patients and B5 and B21 in Indian patients
have been found.8,9
Diagnostic Criteria
In 1988, based on an analysis of 96 patterns Ishikawa
proposed criteria for the clinical diagnosis of TA.10
The criteria consisted of obligatory criteria of age
less than 40 years. Two major criteria of left and right
subclavian artery lesions and nine minor criteria in-
clude hypertension, a high erythrocyte sedimentation
rate and arteriographic demonstration of lesions of
different arteries. In addition to the obligatory crite-
rion, the presence of two major criteria or one major
plus two or more minor criteria, or four or more
minor criteria suggests a high probability of TA. The
criteria have a sensitivity of 84% in patients of TA.
In 1990, the American College of Rheumatology
suggested a set of criteria for the diagnosis of Taka-
yasu arteritis.11 The criteria consist of (a) age <40
years (b) claudication of an extremity, (c) decreased
brachial artery pulse, (d) >10 mmHg difference in
systolic pressure between arms, (e) a bruit in subcla-
vian arteries or aorta and (f) angiography evidence
of narrowing or occlusion of the aorta, its primary
or proximal branches. Presence of three of the six
criteria is required for the diagnosis. These criteria
have a 90.5% sensitivity and 97.8% specificity.
Sharma et al. in 1995 suggested certain modifica-
tions in Ishiwaka’s diagnostic criteria.12 These modifi-
cations included (a) removal of the obligatory criteria
of age, (b) the characteristic signs and symptoms be-
ing made one of the major criteria, (c) removal of
579Editorialage from defining hypertension, (d) deletion of the ab-
sence of aorto-iliac lesion from the ninth minor criteria
and (e) an addition of a tenth minor criteria of coro-
nary artery lesion in patients younger than age 30
years in the absence of risk factors such as hyperlipid-
emia, diabetes mellitus or any other known risk factor.
The presence of two major or one major and two mi-
nor criteria or four minor criteria should suggest
a high probability of TA (Table 1). These modified
criteria seemed more sensitive for the diagnosis of
TA in a series of 106 Indian patients with clinically
and angiographically proven TA (Table 2).13
Imaging Findings
Four basic arteriographic patterns are observed in
patients with Takayasu arteries14:
 Varying degree of aortic and arterial narrowing
 Complete occlusion
 Fusiform or saccular aneurysm
 Irregular contour of aortic wall
The most frequent finding is a localized narrowing
or irregularity of the aortic wall. The narrowing may
progress to significant coarctation and occasionally
total occlusion of aorta or its major branches.
The main and large pulmonary arteries are also
affected as a part of generalized arteritis, with arterio-
graphy revealing a paucity of the pulmonary vessels
in lobar or segmental distribution. According to the
angiographic classification proposed by Ueda et al.
and modified by Lupi HE et al. based on changes of
vascular lumen, namely stenosis, occlusion, wall
irregularity or aneurysm; angiographic findings can
be classified into four types.15,16
 Type I is limited to the aortic arch and its branches.
 Type II affects the descending thoracic and abdo-
minal aorta.
 Type III is extensive form involving the arch and
the thoracic and abdominal aorta.
 Type IV is designated to those cases with pulmo-
nary involvement in addition to the features of
type I, II, or III.
Pre-contrast transverse CT images reveal a high
attenuation wall of variable thickness and of variable
mean CT number in the aorta and major branches.17
CT angiogram demonstrates circumferential wall
thickening of 1e4 mm thickness. The thickened aortic
wall may be enhanced inhomogeneously during the




The most severe stenosis or occlusions
present in the mid portion from the point
1 cm proximal to the vertebral artery
orifice determined by angiography.
Right mid subclavian
artery lesion
The most severe stenosis or occlusions
present in the mid portion from the right
vertebral artery to the point 3 cm distal to





These include limb claudication,
pulselessness or pulse difference
(>10 mmHg systolic blood pressure
difference in limb), fever, neck pain,
transient amaurosis, blurred vision,
syncope, dyspnea or palpitations.
The minor criteria
High ESR Unexplained persistent high ESR
>20 mm/hr (Westergreen) at diagnosis




Unilateral or bilateral tenderness of
common carotid arteries on palpation.
Neck muscle tenderness is unacceptable.
Hypertension Persistent blood pressure in brachial
>149 mmHg, or popliteal >160/









Lobar or segmental arterial occlusion or
equivalent determined by angiography
or perfusion scintigraphy, or presence of
stenosis, aneurysm, luminal irregularity
or any combination on pulmonary trunk
or in unilateral or bilateral pulmonary
arteries determined by angiography.
Left mid common
carotid lesion
Presence of the most severe stenosis or
occlusion in the mid portion of 5 cm in
length from the point 2 cm distal to its
orifice determined by angiography.
Distal brachiocephalic
trunk lesion
Presence of the most severe stenosis or




Narrowing, dilation or aneurysm, luminal
irregularity or any combination




Narrowing, dilation or aneurysm, luminal
irregularity or aneurysm combination.
Coronary artery
lesion
Documented on angiography below the
age of 30 years in the absence of risk factors
like hyperlipidemia or diabetes mellitus.
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580 Editorialfurther mural enhancement of the aorta and its major
branches with Takayasu arteries involvement. The
most characteristic gross pathological features are
marked thickness and rigidity of the wall due to fibro-
sis of all the layers- intima, media and adventitia.17
Clinical Features of Takayasu Arteritis
TA classically progresses through 3 stages:
 An early systemic illness usually associated with
constitutional symptoms and fever.
 A vascular inflammatory phase.
 The inflammation settles down or burns out.
The clinical features that have been ascribed to
Takayasu’s disease are listed in Table 3, according to
the system involved. In 1996, the American National
Institute of Health Investigators reported that only
33 percent of their sixty patients studied had constitu-
tional symptoms or fever, either at presentation or in
the past, and 18 percent of the patients never evolved
into a burned out stage.18
Management
Besides management of hypertension and its complica-
tions, steroids and immunosuppressive agents like
methotrexate and cyclophosphamide are used to
suppress disease activity. Response to therapy is faster
and better in children with a higher rate of remission.19
Anti-platelet agents like aspirin and dipyridamole
have been used especially in patients with transient
neurological symptoms. Role of intravenous immuno-
globulins, recombinant IL-1 receptor antagonist, IL-4
Table 3. Clinical features of Takayasu’s disease
Constitutional Fever (40%), Weight loss (40e60%), Malaise
(40e60%), Anemia (40%), Myalgias (40%),
Arthralgias (40e60%), Arthritis (40%)
Vascular Jaw claudication, Extremity claudication,
Neurological features (60%) includes the
following: Transient ischemic attacks,
Hemorrhagic or ischemic stroke, Transient
or permanent blindness, Headaches, Seizures,
Subclavian steal syndrome.
Cardiac Aortic regurgitation, Angina, Congestive heart
failure (primary cause of death), Arrhythmias
Pulmonary Pulmonary hypertension (often asymptomatic),
Hemoptysis, Pleuritis
Renal Mesangial proliferative glomerulonephritis
with mesangial deposits of IgM, IgG, IgA and
C3 (Most frequent), Membranoproliferative and
crescentric glomerulonephritis, Renal
amyloidosis
Dermatological Ulcerated subacute nodular lesions, Papular
erythematous lesions of hands, Erythema
multiformeEur J Vasc Endovasc Surg Vol 33, May 2007and transforming growth factor b is yet to be
established.
Percutaneous transluminal angioplasty (PCTA) is
the commonest palliative procedure performed with
a success rate varying from 56e80%.20 All lesions are
not amenable to PCTA and surgical bypass procedures
become imperative when stenosis exceeds 70%.21
Irrespective of the surgical procedures undertaken,
the outcome appears to be favorable when the disease
is quiescent. Surgical procedures are required for total
aortic occlusion, severe aortic incompetence, critical
central nervous system ischemia, aneurysms, renovas-
cular hypertension, ostial lesions, tight stenosis, ex-
tensive renal segmental artery involvement, poorly
functioning renal units, renal failure and, occasionally,
in case of failure of angioplasty.
Surgery for TA should be deferred in the active
phase of the disease, which is characterized by an
increased ESR, increased C-reactive protein and
symptoms of fever, malaise or pain over the major ar-
teries, or signs of progressive vascular involvement on
angiography as the chances of thrombosis increase.
Surgery is often difficult in the active disease period
due to more bleeding, friable tissue and the high
chance of thrombosis.
Indian Scenario
The prevalence of Takayasu Arteritis in Indian pa-
tients has been reported in numerous studies. Sen
et al. and Chhertri et al. have reported a female to
male ratio of 1.58:1 in Indian patients.21,22 Indian
male patients with TA have a higher frequency of hy-
pertension and abdominal aorta involvement while
female patients have a tendency towards involvement
of aortic arch and its branches.23 The average age of
the Indian patient presentation is in the third decade.
The disease has been observed to present in second
decade in Latin America, third decade in Japanese
and fifth decade in Swedish patients.24
The majority of Indian patients had hypertension at
the time of presentation and only 16% of patients had
constitutional symptoms of fever weight loss and
arthralgia.25 Hypertension has been a predominant
feature in most of the studies from India.1,2,25 It com-
monly results from the involvement of renal arteries
(involved in 20e90% cases in different series).24,25
Kumar A et al. reported that for young patients with
renovascular hypertension, the predominant cause
was TA (69.4%).26 Bilateral involvement of the renal
arteries is common in patients with TA (60%).26
Kumar A et al. reported the presence of congestive
cardiac failure in patients of TA.26 It was related to
hypertension and the possible involvement of
581Editorialmyocardium has also been described by Talwar et al.27
The incidence of aortic regurgitation has been low (7e
15%) in many series from India but Subramaniyan
et al. have reported a higher incidence (24%).24,25
Kasuya et al. have reported that patients with TA and
HLA Bw52 antigen have a more severe left ventricular
involvement.28 In Japan, TA frequently involves the aor-
tic arch and the branches arising from it. In contrast, ab-
dominal aorta and its branches are frequently involved
in Indian patients occurring in 79% of patients.25,29
Dhingra et al. had detected anti-aortic antibodies in
patients with TA.30 Sima et al. demonstrated anti-
endothelial antibodies by enzyme linked immunoab-
sorbent assay.31 Misra et al. have reported elevated
titers of IgG anticardiolipin antibodies in 14 of 34
patients of TA.32 They had also documented an
elevated CD4þ subset of T lymphocytes in patients
with TA.33 An expansion of CD4þ : CD8þ ratio, a
high basal protein kinase activity and a high intracellu-
lar calcium concentration has been observed.33 These
features suggested that the circulating lymphocytes in
TA are in an activated state but the exact stimulus for
activation still remains obscure. An increase in CD8
positive Tcell subsets, increased IgG and IgM immuno-
globulin levels, and the presence of autoantibodies
including ANA, ANCA, anticardiolipin and anti-beta
2GPI antibodies in TA patients. The strikingly positive
responses to tuberculin, as well as the multi-test CMI
also indicate exaggerated T cell responses and cell
mediated immunity in Takayasu’s arteritis.34
As most of Indian patients present in the chronic
phase, steroid therapy has not been used very com-
monly, though it is being employed more frequently
than in the past.33
Khalilullah et al., Sharma et al. and Kumar et al. have
reported a high success rate with percutaneous translu-
minal angioplasty of renal, subclavian and iliac artery le-
sions.20,35,36 The clinical benefit of renal angioplasty was
seen in 85% of TA cases.26 However, re-stenosis occurred
in 24.23% cases at a median follow up of 4.6 years.26 In
earlier studies of balloon angioplasty for TA, Tyagi
et al. reported a re-stenosis rate of 25.8% in 31 renal units,
whereas Sharma et al. reported re-stenosis rate of 20% in
40 patients.37,38 Although re-stenosis is a common prob-
lem of PTRA for TA, repeat procedures have provided
good results. In most angioplasty series of TA, tight ostial
stenosis and longer renal artery stenosis length are asso-
ciated with higher re-stenosis rates.
Conclusion
Takayasu Arthritis remains the commonest cause
of renovascular hypertension in India. Better understanding of disease aetiology and pathogenesis is
required for better outcomes in the future.
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